People in the News - News Updates
Find out the latest news about DCEG Staff: awards and recognition, hirings and promotions, and engagement at scientific conferences.
-
Marianne K. Henderson, M.S., CPC, Senior Advisor for Division Resources received the 2022 Pioneer’s Award from the International Society for Biological and Environmental Repositories (ISBER). She was recognized for providing outstanding leadership to the founding, support, and incorporation of ISBER as an international biobanking society, and for playing a critical role in developing and executing ISBER’s vision and mission.
-
In April 2022, Dr. Berrington was appointed as the Vice-Chair of the National Academies Nuclear and Radiation Studies Board.
-
DCEG Intramural Research Awards are competitive funding opportunities designed to foster creative, high-impact research by fellows and tenure-track investigators.
-
DCEG has partnered with the Health Resources and Services Administration Office of Women’s Health, the Centers for Disease Control and Prevention, and other agencies and offices to bring cervical cancer prevention and management guidelines into safety-net settings of care, an offshoot of the Cancer Moonshot.
-
In April 2022, staff scientists and staff clinicians from DCEG, the NCI Center for Cancer Research, and Frederick National Laboratory, gathered virtually for their 18th annual scientific retreat on “Fostering innovation in cancer research, path from discovery to therapy.”
-
Postbaccalaureate fellows in DCEG presented their research at the virtual 2022 NIH Postbac Poster Day, sponsored by the NIH Office of Intramural Training and Education.
-
Dr. Wong will develop, implement, and provide key bioinformatics leadership, expertise, and support to the Division, and serve as the head for a newly established DCEG Bioinformatics Virtual Core (BVC).
-
Four investigators were recognized for outstanding mentorship in 2021: Jonas Almeida, Megan Clarke, Rena Jones, Minkyo Song. Read excerpts from the nominations prepared by their trainees.
-
Ludmila Prokunina-Olsson received the 2022 International Cytokine & Interferon Society Mentorship Award in recognition of her significant contributions to the field of immunity and cancer genetics and training, nurturing, and guiding the next generation of scientists.
-
DCEG investigators and fellows presented their research at the 2022 American Association for Cancer Research (AACR) Annual Meeting.
-
In April 2022, Shahinaz Gadalla, Ph.D., M.B.Bch., was awarded scientific tenure by the NIH and promoted to senior investigator in the Clinical Genetics Branch. Dr. Gadalla is a highly collaborative, internationally recognized physician scientist with expertise in cancer epidemiology and clinical medicine. She investigates the role of genetic factors in cancer etiology and explores elements that may modify disease risk among high-risk individuals.
-
Dr. Mbulaiteye, senior investigator in the Infections and Immunoepidemiology Branch, was recently recognized by the Lymphoma Foundation of America with their 2022 Scientist of the Year Award. As a part of this award, he directed a donation from the foundation to a study site in Uganda for medical care for children with Burkitt lymphoma.
-
Three projects were funding through the Flex Award Program, including two investigations of health disparities. Investigators from DCEG: Drs. Jiyeon Choi, Maria Teresa Landi, Tongwu Zhang, Gretchen Gierach, Aimée R. Kreimer, Lisa Mirabello, and Mark Schiffman.
-
Dr. Beane Freeman has been re-elected by her peers to a second term as DCEG Women Scientist Advisor (WSA).
-
In February 2022, the Panel released their report “Closing Gaps in Cancer Screening: Connecting People, Communities, and Systems to Improve Equity and Access,” in which they identify more effective and equitable implementation of cancer screening as a significant opportunity for the National Cancer Program, to accelerate the decline in cancer deaths and, in some cases, prevent cancer through detection and removal of precancerous lesions.
-
Several DCEG staff were honored at the 2021 NCI Director’s Awards ceremony for their efforts in advancing understanding of the etiology of multiple myeloma, non-smoking-related lung cancer; mosaic chromosomal alterations and risk of acquiring infectious disease; their work on The United States – Latin America Cancer Research Network Team; leadership on the Equity and Inclusion Program; and for years of continued service to the NCI.
-
Ian Buller, Ph.D., Erping Long, M.D., Ph.D., Zeni Wu, Ph.D., M.P.H., Tongwu Zhang, Ph.D., and Wei Zhao, Ph.D., received the 2022 NCI Director’s Innovation Awards, designed to support development of highly innovative approaches and technology aimed at significant cancer–related problems.
-
Jonathan Hofmann, Ph.D., M.P.H., was awarded scientific tenure by the NIH and promoted to senior investigator in the Occupational and Environmental Epidemiology Branch. He is an internationally recognized leader in using molecular approaches to study the etiology of kidney cancer, multiple myeloma, and other malignancies.
-
Postdoctoral fellows Burak Altintas, M.D., in the Clinical Genetics Branch, Brittany Lord, Ph.D., M.P.H., M.S., and Waruiru Mburu, Ph.D., M.P.H., in the Integrative Tumor Epidemiology Branch, Omonefe Omofuma, Ph.D., M.S., in the Metabolic Epidemiology Branch, and Elisa Pasqual, Ph.D., in the Radiation Epidemiology Branch were selected for the 2022 NCI Career Development Program (CDP).
-
Roni Falk, M.S., staff scientist in the Metabolic Epidemiology Branch (MEB) retired after 38 years of service to the NCI. Ms. Falk made critical contributions to epidemiologic studies on endogenous hormones and cancer risk.